ERBB2 and breast carcinoma: Differentially expressed genes identified by class comparison analysis between luminal HER2+ and basal BCCLs treated with CM from CAF or from NAF were used for building three different microenvironment signatures representative of stromal effect on breast cancer cells belonging to the three different subtypes (μENVlum, μENVHER2, and μENVbasal).